Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05636592
What this trial is testing

Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 250
Early research (Phase 1)Looking for participantsNCT06896188
What this trial is testing

9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)

Who this might be right for
Pancreatic Adenocarcinoma
Anwaar Saeed 12
Testing effectiveness (Phase 2)Study completedNCT05166239
What this trial is testing

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Peking University 66
Not applicableStudy completedNCT06024356
What this trial is testing

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer

Who this might be right for
Colorectal Neoplasms
Beijing Friendship Hospital 47
Testing effectiveness (Phase 2)Looking for participantsNCT07277439
What this trial is testing

Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma

Who this might be right for
Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University 48
Not applicableLooking for participantsNCT07283575
What this trial is testing

Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)

Who this might be right for
Metastatic Colorectal Cancer ctDNA Surveillance
Fudan University 497
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631325
What this trial is testing

Axelopran and Nivolumab in PD-1-Refractory Metastatic Melanoma

Who this might be right for
Unresectable Cutaneous Melanoma
John Kirkwood 28
Not applicableStudy completedNCT07053215
What this trial is testing

Efficacy of Argon-Helium Cryoablation Plus PD-1 Inhibitors in NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
The First Hospital of Hebei Medical University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07230639
What this trial is testing

Node-Sparing Hypofractionated Radiotherapy Plus Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Randomized, Phase II Trial

Who this might be right for
Neoadjuvant TherapiesImmune Checkpoint TherapyRadiotherapy
Sixth Affiliated Hospital, Sun Yat-sen University 52
Testing effectiveness (Phase 2)Study completedNCT04539444
What this trial is testing

CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma

Who this might be right for
Relapsed Non Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University 18
Early research (Phase 1)Not Yet RecruitingNCT07422363
What this trial is testing

Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma, IDH-WildtypeRecurrent GliosarcomaRecurrent WHO Grade 4 Glioma
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06375109
What this trial is testing

PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC

Who this might be right for
Limited-stage Small-cell Lung Cancer
Beijing Chest Hospital, Capital Medical University 60
Very early researchActive Not RecruitingNCT04134325
What this trial is testing

Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma

Who this might be right for
Relapsed Hodgkin LymphomaRefractory Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT05758389
What this trial is testing

Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors

Who this might be right for
Head and Neck Tumors
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 29
Large-scale testing (Phase 3)Active Not RecruitingNCT05219318
What this trial is testing

Treatment Pause Versus Treatment Continuation in IMDC Good or Intermediate Risk With Only One Adverse Prognostic Factor in mRCC Patients With an Objective Response at 12 Months of Treatment With PD1/ PDL1 ICIs + VEGFR-Tyrosine Kinase Inhibitors

Who this might be right for
Metastatic Renal Cell CarcinomaGood or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score
University Hospital, Bordeaux 22
Testing effectiveness (Phase 2)UnknownNCT04624308
What this trial is testing

Toripalimab Plus TPF Chemotherapy and Radiotherapy for LA-HPSCC

Who this might be right for
Hypopharyngeal Neoplasm Malignant Primary
Sun Yan 81
Large-scale testing (Phase 3)WithdrawnNCT06866951
What this trial is testing

A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized Controlled Clinical Trial

Who this might be right for
Cervical Cancers
Women's Hospital School Of Medicine Zhejiang University
Testing effectiveness (Phase 2)Looking for participantsNCT06751901
What this trial is testing

Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

Who this might be right for
Advanced NSCLC
The First Affiliated Hospital of Nanchang University 10
Large-scale testing (Phase 3)WithdrawnNCT03744247
What this trial is testing

Lenvatinib Plus PD-1 Antibody Versus Lenvtinib Alone for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University
Testing effectiveness (Phase 2)UnknownNCT03993626
What this trial is testing

A Trial of CXD101 in Combination With Nivolumab in Patients With Metastatic Microsatellite-Stable Colorectal Cancer

Who this might be right for
Colorectal Neoplasms Malignant
Celleron Therapeutics Ltd. 55
Next Page